Cencora, Inc. (COR) Free Cash Flow (FCF): $1.56B
The free cash flow (FCF) for Cencora, Inc. (COR) is $1.56B. It is below its 12-month average by 49.78% ($3.10B).
COR Free Cash Flow (FCF) Chart
COR Average Free Cash Flow (FCF) Chart
COR Current vs Average Free Cash Flow (FCF) Chart
COR Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$1.56B
FREE CASH FLOW (FCF) AVG TTM
$3.10B
FREE CASH FLOW (FCF) AVG 3Y
$2.97B
FREE CASH FLOW (FCF) AVG 5Y
$2.66B
FREE CASH FLOW (FCF) AVG 10Y
$2.41B
FREE CASH FLOW (FCF) AVG 15Y
$1.96B
FREE CASH FLOW (FCF) AVG 20Y
$1.70B
CURRENT VS TTM AVG
-49.78%
CURRENT VS 3Y AVG
-47.47%
CURRENT VS 5Y AVG
-41.31%
CURRENT VS 10Y AVG
-35.24%
CURRENT VS 15Y AVG
-20.39%
CURRENT VS 20Y AVG
-8.24%
FCF Analysis
Free Cash Flow (TTM)
$1.56B
FCF Yield
2.83%
Price/FCF
35.3
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Cencora, Inc. Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cencora, Inc. Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for Cencora, Inc. (COR)?
- The free cash flow (FCF) for COR stock is $1.56B.
- What is the TTM average free cash flow (FCF) for Cencora, Inc. (COR)?
- The TTM average free cash flow (FCF) for COR stock is $3.10B.
- What is the 3Y average free cash flow (FCF) for Cencora, Inc. (COR)?
- The 3Y average free cash flow (FCF) for COR stock is $2.97B.
- What is the 5Y average free cash flow (FCF) for Cencora, Inc. (COR)?
- The 5Y average free cash flow (FCF) for COR stock is $2.66B.
- What is the 10Y average free cash flow (FCF) for Cencora, Inc. (COR)?
- The 10Y average free cash flow (FCF) for COR stock is $2.41B.
- What is the 15Y average free cash flow (FCF) for Cencora, Inc. (COR)?
- The 15Y average free cash flow (FCF) for COR stock is $1.96B.
- What is the 20Y average free cash flow (FCF) for Cencora, Inc. (COR)?
- The 20Y average free cash flow (FCF) for COR stock is $1.70B.
Cencora, Inc. Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2025-09-30 | $3.21B |
| 2024-09-30 | $3.00B |
| 2023-09-30 | $3.45B |
| 2022-09-30 | $2.21B |
| 2021-09-30 | $2.23B |
| 2020-09-30 | $1.84B |
| 2019-09-30 | $2.03B |
| 2018-09-30 | $1.07B |
| 2017-09-30 | $1.02B |
| 2016-09-30 | $2.71B |
| 2015-09-30 | $3.69B |
| 2014-09-30 | $1.20B |
| 2013-09-30 | $585.67M |
| 2012-09-30 | $1.14B |
| 2011-09-30 | $999.99M |
| 2010-09-30 | $923.99M |
| 2009-09-30 | $637.93M |
| 2008-09-30 | $599.76M |
| 2007-09-30 | $1.09B |
| 2006-09-30 | $694.13M |
| 2005-09-30 | $1.32B |
| 2004-09-30 | $635.80M |
| 2003-09-30 | $264.26M |
| 2002-09-30 | $471.77M |
| 2001-09-30 | $-63.37M |
| 2000-09-30 | $199.96M |
| 1999-09-30 | $-12.80M |
| 1998-09-30 | $115.50M |
| 1997-09-30 | $-25.20M |
| 1996-09-30 | $24.30M |
Related Metrics
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch